PaulJiL Profile Banner
Pablo Jiménez Profile
Pablo Jiménez

@PaulJiL

Followers
458
Following
513
Media
147
Statuses
423

Medical Oncologist. MD MSc. Clinical Research Fellow. The Royal Marsden NHS. Interested in HN,CSCC,SupportCare&Early phase Clinical Trials! Tweets my own.

London, England
Joined May 2011
Don't wanna be here? Send us removal request.
@OncoAlert
OncoAlert
2 days
A Huge Shout out to the #OncoAlertAF 🚨 What we do We do as A Team Thank you all for your support!! Final Meeting of 2025 (1 of 2) Loads of Great Initiatives COMING your way in 2026! #OncoAlertAF @nataliagandur @acampsmalea @BRicciutiMD @HHorinouchi @FadiHaddad_MD @Abdallah81MD
1
11
21
@OncoAlert
OncoAlert
3 days
Dear Colleagues at #SABCS25 Just to let you know that we will be all the Great Science out of San Antonio will be Discussed in February 2026 for the 6th Annual OncoAlert Colloquium 🚨 REGISTER👉 https://t.co/cp9aGU7SyG We started faculty confirmation yesterday and the line up
0
10
13
@PaulJiL
Pablo Jiménez
5 days
#ESMOAsia25 🚨JUPITER-02 Final 6-year OS analysis presented! 1L toripalimab + gem/cis in pts with RM-Nasopharyngeal Ca Median OS 64.8 vs 33.7 mo (HR 0.62; p<0.01) Adjusted post-prog IO: 61.0 vs 25.1 mo (HR O.52) Confirms long-term toriGP combo efficacy 👇Updated situation
@PaulJiL
Pablo Jiménez
1 month
Still work to do by western regulatory agencies to ensure access to immuno-chemo combos for patients with R/M nasopharyngeal carcinoma Players⛹🏾‍♂️⛹🏽‍♀️ toripalimab, tislelizumab, penpulimab, camrelizumab @brunolarvol @BAHNOOfficial @OracleHNCUK @OncoAlert @ttccgroup Among others 🇬🇧
0
5
11
@NXT4EU
NXT EU
6 days
X today...
210
623
9K
@RenewEurope
Renew Europe
6 days
Musk wants to break up the EU. Putin wants a weaker EU. China wants to divide the EU. Trump wants a far-right EU. WE want a STRONGER EU. Are you with us? 🇪🇺🇪🇺🇪🇺
7K
2K
15K
@PaulJiL
Pablo Jiménez
13 days
Enormous thanks for their collaboration to @PatelOncology @TonyMok9 @ChiaraCrem1 @carlottanto
0
0
2
@PaulJiL
Pablo Jiménez
13 days
Just published the full manuscript about our meta-analyses on second-event endpoints (EFS2/PRFS2/PFS2) in antiPD(L)1 trials in @jitcancer 47 RCTs. 34,973 patients 🔸In meta-regressions, prior AntiPD(L)1s exposition reduced/delayed subsequent PD events compared with IO-naïve pts
Tweet card summary image
jitc.bmj.com
Background Immune checkpoint inhibitors (ICIs), particularly anti-PD-(L)1s, have transformed cancer care by their extended efficacy, even receiving next-line. Event-free survival 2 (EFS2), progress...
1
0
5
@PaulJiL
Pablo Jiménez
17 days
Eradicating cervical cancer is possible! 👇Australia ZERO incidence for the first time among women aged 20-24, thanks to HPV vaccination👏👏 Australia is committed to eliminate cervix ca by 2035 Source @nhmrc https://t.co/NZU9tuFY7C @OncoAlert @brunolarvol #OncoAlertAF
0
1
6
@PaulJiL
Pablo Jiménez
19 days
Sensitive and timely call for patient selection and non-reflex NGS testing in patients with sarcoma, applicable to other rare condiditions 🔸Importance of expect centers 🔸Pathology Review 🔸Findings and context by @DrCeSarcoma @jeanyvesblay Dr Sebastien Bauer Link:
0
9
19
@PaulJiL
Pablo Jiménez
19 days
Merus will try to design a subcutaneous version of petosentamab If this will be succesfull as sc amivantamab, it would suppose reducing reactions and possibly lessen heavy premedication currently required @OncoAlert @brunolarvol #MCLA2 #MCLA3 #Liger1 #liger2 #headandneck
0
2
7
@AntiTrumpCanada
Canada Hates Trump
20 days
Good morning to all the MAGA patriots working overtime in Nigeria, India, Kenya, Pakistan, Russia and Bangladesh. Nothing says “America First” like tweeting from six different continents. 🌍🇺🇸
1K
18K
80K
@SGCancerUK
Salivary Gland Cancer | Charity
21 days
TRIAL OPEN: Dry Mouth Relief After Radiotherapy. New hope for dry mouth after radiotherapy! The AQUAx2 Study is investigating a gene therapy for xerostomia. Learn more and check eligibility: https://t.co/tuURjrMcVc #ClinicalTrials #SGC
0
3
3
@SGCancerUK
Salivary Gland Cancer | Charity
1 month
It's #MouthCancerActionMonth, and checking your mouth is vital - rare cancers often get missed Early detection is crucial. Be Aware Be Specific. If you spot anything unusual, ask your GP or dentist for a specific referral to a specialist. #RareCancer #SalivaryGlandCancer
0
8
6
@EricTopol
Eric Topol
1 month
No clear evidence to support any link between maternal acetaminophen (Tylenol) intake and autism or ADHD in offspring, a new umbrella systematic review @bmj_latest
50
290
861
@PaulJiL
Pablo Jiménez
1 month
Still work to do by western regulatory agencies to ensure access to immuno-chemo combos for patients with R/M nasopharyngeal carcinoma Players⛹🏾‍♂️⛹🏽‍♀️ toripalimab, tislelizumab, penpulimab, camrelizumab @brunolarvol @BAHNOOfficial @OracleHNCUK @OncoAlert @ttccgroup Among others 🇬🇧
1
4
13